Biotech Values

[jq1234]

as long as MNTA sticks to funding no more than 25% of the next Phase 2b trial of M118 with a partner

Why would a partner require MNTA fund 25% of phase 2b trial only? I took MNTA would not start phase 2b trial on its own as that they could fund phase 2b trial on its own if there would be a partner who would fund phase III. Funding a portion of phase III requires huge financial commitment from MNTA.